John J Orloff Alexion Pharmaceuticals, Inc. (ALXN) insider trading activity
John J Orloff is EVP, Research & Development of ALEXION PHARMACEUTICALS, INC.. Currently has a direct ownership of 0 shares of ALXN, which is worth approximately $0. The most recent transaction as insider was on Jul 21, 2021, when has been sold 146,511 shares (Common Stock, par value $.0001 per share) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
0
0%
3M change
0%
12M change
Total Value Held
$0
JOHN J ORLOFF Transaction History
JJO
John J Orloff
EVP, Research & Development
Boston, MA